Type-2 Diabetes Market Expanding at a CAGR of 8.0% during 2023-28: MarkNtel Advisors

The Global Type-2 Diabetes Market is projected to grow at a CAGR of around 8.0% during the forecast period, i.e., 2023-28.

irene garcia irene garcia
Sep 2, 2024 - 12:55
3

Share this Post to earn Money ( Upto ₹100 per 1000 Views )


Type-2 Diabetes Market Expanding at a CAGR of 8.0% during 2023-28: MarkNtel Advisors

Global Type-2 Diabetes Market Overview:

MarkNtel Advisors has recently published a detailed research report on the Global Type-2 Diabetes Market. The report is specifically tailored to offer valuable insights and support for clients navigating this dynamic market. It focuses on key objectives such as predicting trends, gaining a profound understanding of market perspectives, identifying strategic investment opportunities, and evaluating potential business partners.

Type-2 Diabetes Market Insights and Analysis

The Global Type-2 Diabetes Market is projected to grow at a CAGR of around 8.0% during the forecast period, i.e., 2023-28. Our comprehensive report provides a thorough examination of market players, opportunities, and valuable insights, equipping our clients with the indispensable information needed to make well-informed decisions within this dynamically evolving environment.

In case you missed it, we are currently revising our reports. Click on the "request sample report" button to get the latest research data with forecast for the years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.

Insights into Dominant Segments in the Type-2 Diabetes Market

By analysing each Segments, including

-By Gender

  • Male
  • Female

Between the two, the Women segment held a significant market share in the Global Type-2 Diabetes market in 2022, owing to the alarming rise in the prevalence of type-2 diabetes among pregnant women. Due to multiple adverse pregnancy outcomes, the development of gestational diabetes is high among pregnant women. Besides, the chance of developing type 2 diabetes is higher, especially three to six years after delivery. Moreover, exposure to hyperglycemia in the womb affects the health of children later, resulting in being overweight, making them more prone to developing type 2 diabetes in the coming years. Thus, it is projected to accentuate the market growth of type-2 diabetes in the forecasted period.

-By Drug Type

  • Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
  • Alpha-glucosidase Inhibitors
  • Biguanides
  • Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
  • Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2)
  • Sulfonylureas
  • Other (Thiazolidinediones, Meglitinides, Glitazones, etc.)

-By Age Group

  • Upto 19 years
  • 20 – 65 years
  • Above 65 years

Explore Our Comprehensive Study:  https://www.marknteladvisors.com/research-library/global-type-2-diabetes-market.html

Type-2 Diabetes Market Geographical Reach:

The Type-2 Diabetes Market Geographical Reach assesses the distribution and prominence of consumption, highlighting regions that dominate in terms of market size, volume, and promising future growth prospects.

-By Region

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia Pacific

Clients can concentrate their investments on the segments that present the most favourable prospects. This strategic methodology empowers clients to fine-tune their investment portfolio and attain enduring growth within the Type-2 Diabetes market.

Current Landscape of Type-2 Diabetes Market

The key players profiled in the research report are

  • Merck & Co
  • AstraZeneca
  • Novo Nordisk
  • Bristol-Myers Squibb
  • Eli Lilly
  • Sanofi
  • Boehringer Ingelheim
  • Pfizer
  • Takeda
  • Biocon
  • Johnson & Johnson

In light of the ongoing rapid transformations within the Type-2 Diabetes market, retaining a strategic advantage is paramount for both businesses and investors. At MarkNtel Advisors, we exactly identify and study every notable player, taking into account their recent product launches, mergers, acquisitions, and collaborations. This thorough analysis assists our clients in making more accurate projections and staying competitive in the market.

Type-2 Diabetes Market Future Prospects

The outlook for Type-2 Diabetes appears favourable in terms of both revenue share and sales, as evidenced by the market trends. Anticipating continued robust growth over the next five years. market participants are expected to further bolster their portfolios by harnessing technological advancements within the industry. Adding to the market's attractiveness is the widespread application of the product/service across various end-users, allowing market players to establish a solid presence across continents.

Customization of Reports Available - https://www.marknteladvisors.com/query/request-customization/global-type-2-diabetes-market.html

Recent Developments in the Global Type-2 Diabetes Market

  • In August 2022, AstraZeneca's diabetes drug Farxiga exhibits significant reductions in hospitalization and death risks among patients with all types of heart failure.
  • In June 2022, AstraZeneca’s Bydureon BCise, an exenatide 2 mg prolonged-release suspension for injection in a pre-filled pen, has been approved to include in the treatment of type-2 diabetes (T2D) in children and adolescents (10 years and above) in the European Union (EU).

Frequently Asked Questions

What predictions can be formulated concerning market share, product accessibility, and the demand from consumers?

What pivotal factors are influencing the dynamics of the Type-2 Diabetes Market?

What lies ahead in terms of future opportunities for the Type-2 Diabetes Market?

What obstacles are businesses encountering as they navigate the Type-2 Diabetes Market?

Who are the prominent players driving developments in the Type-2 Diabetes Market?

Related Reports

Why choose MarkNtel?

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-08.011

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Tags: